Latest Circulating Tumor Cell Stories
RARITAN, N.J., Jan.
A new study suggests that the presence of tumor cells in the circulating blood of patients with squamous cell cancer of the head and neck may predict disease recurrence and reduced survival.
A high level of circulating tumor cells (CTCs) â€” cells that have detached from a tumor and are circulating in the body through the blood â€” are an independent prognostic marker in metastatic breast cancer as first-line therapy.
Metastatic breast cancer patients who had circulating tumor cells (CTCs) in their blood before or after high-dose chemotherapy (HDCT) followed by autologous stem cell transplantation had poor outcomes.
Metastatic breast cancer patients whose blood contains circulating tumor cells (CTCs) before or after treatment with high-dose chemotherapy and blood stem cell transplant have shorter survival periods.
The process of metastasis requires that cancer cells traveling from a primary tumor find a hospitable environment in which to implant themselves and grow.
Redesigned microchip-based device provides more data, finds previously unseen CTC clusters.
HAYWARD, Calif., Oct. 8 /PRNewswire/ -- Advanced Cell Diagnostics, Inc. (ACD) was awarded a three-year, $3 million grant from National Cancer Institute (NCI) under its SBIR Phase II Bridge Award.
Scientists can now learn how drugs work in clinical trials thanks to an innovative technological advance that makes nanoscale protein measurements.
Circulating tumor cells may create a new alternative and non-invasive source for biomarker assessment a new study shows.
- To swell, as grain or wood with water.